(Q36053563)

11 August 2017

The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers (English)

1 reference

11 August 2017

1 reference

A D Van Haarst

1

1 reference

11 August 2017

J M Van Gerven

2

1 reference

11 August 2017

A F Cohen

3

1 reference

11 August 2017

M De Smet

4

1 reference

11 August 2017

A Sterrett

5

1 reference

11 August 2017

K L Birk

6

1 reference

11 August 2017

A L Fisher

7

1 reference

11 August 2017

M E De Puy

8

1 reference

11 August 2017

M R Goldberg

9

1 reference

11 August 2017

D G Musson

10

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

48

1 reference

11 August 2017

2

1 reference

11 August 2017

190-196

1 reference

Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90)

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014288

Quantitation of the 5HT1D agonists MK-462 and sumatriptan in plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014288

Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014288

Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014288

Pharmacology of moclobemide

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014288

The safety of concomitant use of sumatriptan and antidepressant treatments

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014288

Monoamine oxidase-A: pharmacodynamics in humans of moclobemide, a reversible and selective inhibitor

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014288

Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014288

Novel substrates and products of amine oxidase-catalysed reactions

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014288

Tyramine pressor effect in man: studies with moclobemide, a novel, reversible monoamine oxidase inhibitor.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014288

Determination and comparison of the pressor effect of tyramine during long-term moclobemide and tranylcypromine treatment in healthy volunteers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014288

Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014288

Effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressor effect of tyramine.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014288

The use of sumatriptan in patients on monoamine oxidase inhibitors

23 September 2018

1 reference

12 December 2020

The tolerability and pharmacokinetics of the novel antimigraine compound 311C90 in healthy male volunteers

1 reference

12 December 2020

Initial human experience with MK-462 (rizatriptan): a novel 5-HT1D agonist

1 reference

12 December 2020

Biochemical effects of high single doses of moclobemide in man: correlation with plasma concentrations

1 reference

12 December 2020

Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver

1 reference

12 December 2020

The use of stable isotope labeling and liquid chromatography/tandem mass spectrometry techniques to study the pharmacokinetics and bioavailability of the antimigraine drug, MK-0462 (rizatriptan) in dogs

1 reference

12 December 2020

10.1046/J.1365-2125.1999.00011.X

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

10417495

1 reference